|
|
||||||||
a Department of Critical Care Medicine, University of Florence, Florence, Italy
b Department of Cardiac Surgery, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Donato Hospital, Milan, Italy
c Silesian Medical University Katowice, Silesian Center for Heart Diseases, Zabrze, Poland
Accepted for publication October 16, 2008.
* Address correspondence to Dr Di Donato, Department of Cardiac Surgery, IRCCS, San Donato Hospital, Via Morandi 30, San Donato Milanese, 20097, Italy (Email: marad{at}tin.it).
| Abstract |
|---|
|
|
|---|
Methods: Echo studies of 178 patients were retrospectively reviewed. Three types of LV shape abnormalities were identified: type 1 (true aneurysm), type 2 (nonaneurysmal lesions defined as intermediate cardiomyopathy), and type 3 (ischemic dilated cardiomyopathy).
Results: SVR induced significant improvement in cardiac and clinical status in all patients, regardless LV shape types. Although not significant, mortality was higher in types 2 and 3.
Conclusions: Ischemic dilated cardiomyopathy and not just the true aneurysm can be successfully treated with SVR. Shape classification may be useful to improve patient selection and compare results from different institutions that are otherwise impossible to compare.
| Introduction |
|---|
|
|
|---|
Surgical ventricular restoration (SVR) as described by Dor and colleagues [8] was introduced to improve geometric reconstruction with respect to standard linear repair in LV aneurysm. Subsequently, Dor and colleagues [9, 10] described that the technique was applicable not only to the classic aneurysm but also to large akinetic ventricles. The Dor experience has changed the approach to ischemic failing ventricles, leading surgeons to address more and more dilated and dysfunctioning ventricles in patients who have sustained a MI.
However, patient selection and a clear definition of shape abnormalities of the ventricles that are treated with SVR are lacking in the reported series [11–13], and there are no data that relate effectiveness of SVR to baseline LV shape. Furthermore, there is no consensus on the benefit of this surgical procedure (with defined mortality) in patients with markedly dilated ventricle, where there is no clear demarcation between scarred and normal tissue and where there is associated mitral regurgitation. Many surgeons have been concerned that these patients have higher mortality and worse long-term survival.
Shape classification and its relative importance for outcome in terms of cardiac function, mortality, and survival after SVR, and is considered to be important in view of the numerous SVR patient cohorts presented in published reports in which there is a mixture of all types of morphology, ranging from the true, small postinfarction aneurysm to pure, globally dilated ischemic cardiomyopathy. It is therefore impossible to compare data among series. The objective of the present study is to describe LV shape abnormalities after MI and to assess their influence on clinical and cardiac status and survival in patients who undergo SVR.
| Patients and Methods |
|---|
|
|
|---|
This is a retrospective study based on the institutional database of the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato (July 2001 to date) for patients undergoing SVR. The study design was submitted to the local Ethics Committee, which waived the need for approval in consideration of the retrospective nature of the study. All the patients admitted to the study gave informed consent to the scientific analysis of their clinical data in an anonymous form.
Shape Analysis
LV shape assessment can be done using the Fourier or radius of curvature analysis [14], whereas wall motion asynergy (ie, akinesia/dyskinesia) is detected by evaluating shortening of regions, segments, or chords of the LV [10]. In a previous study we classified three types of shape abnormalities: type 1, 2, and 3 (Fig 1). The LV shape was evaluated in that study quantitatively by calculating the power spectrum and the regional curvatures of angiographic outlines as seen in the right oblique anterior projection. Regional curvatures (the reciprocal of internal radius, l/r) were calculated in the ventricular perimeter starting from the mitral corner and extending to the aortic corner. The power spectrum was calculated by means of Fourier analysis [15–17] (see description in Fig 2).
|
|
|
The degree of mitral regurgitation was assessed in a semi-quantitative way using the following scale: absent, 0; trivial, 1+ mild, 2+ moderate, 3+ and severe, 4+.
Surgical Technique
Details of the surgical technique have been previously reported [19]. The procedure is conducted on arrested heart with antegrade crystalloid or cold blood cardioplegia. Complete coronary artery bypass grafting is first performed, almost always with the left internal mammary artery on left anterior descending and sequential venous grafts on the right and circumflex arteries, when needed. After coronary grafting is completed, the LV is opened with an incision parallel to the left anterior descending artery, starting at the middle scarred region and ending at the apex. The ventricular cavity is inspected and thrombi are removed if they are present. Each papillary muscle head is identified, and the mitral valve leaflets and chords are evaluated.
SVR is performed using a mannequin (TRISVR, Chase Medical, Richardson, TX) filled at 50 to 60 mL/m2 to optimize size and shape. Mitral repair is performed after coronary grafting, if needed. Indication for mitral repair is moderate to severe mitral regurgitation (grade 3/4+) or mitral annulus dilatation (> 38 mm) if mitral regurgitation is mild (grade 2+).
The technique of mitral repair is posterior annulus suture through the ventricular opening in all cases. A double arm stitch running from trigone to trigone is tied on a 26-mm sizer, inserted through the mitral orifice, to undersize the mitral area [19].
Statistical Analysis
The continuous variables are expressed as mean values ± standard deviation. The two-tailed paired t test and the unpaired t test were used when appropriate. One-way analysis of variance was applied to compare groups. Pearson correlation and
2 test were also used. Variables resulting significant at univariate analysis were entered into multivariate regression analysis to assess mortality risk. Kaplan-Meyer actuarial survival was calculated for the three shape types, and differences between groups were assessed using the log-rank test. SPSS 9.0 software (SPSS Inc, Chicago, IL) was used for the analysis.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
Figure 5 shows Kaplan-Meyer survival curve by baseline LV shape. A trend towards a higher mortality rate in type 2 and 3 is observed; however, survival rate is not significantly different.
|
| Comment |
|---|
|
|
|---|
Survival of patients undergoing SVR reported by the Reconstructive Endoventricular Surgery Returning Torsion Original Radius Elliptical (RESTORE) group [11] evidenced that patients with akinesia had significantly lower survival in respect to dyskinesia. Akinesia and dyskinesia in that study referred to visually inspected regional wall motion abnormalities; in the present study, we did not stratify patients on regional wall motion but on LV shape, and we may have had akinesia or dyskinesia in any LV shape. In a previous article, we demonstrated that SVR outcome is related to the extent of asynergy and not to the type of asynergy (ie, akinesia or dyskinesia) [10]. In the present study, shape classification was easily obtained by an echo 2-chamber view in a qualitative way (Fig 3), avoiding more complex and time-consuming Fourier analysis [14].
Regional or Global LV Shape Changes
We think that a clear definition of LV shape is important to compare results after SVR in different series; otherwise, results are impossible to compare because the published reports contain a mixture of all types of morphology, ranging from true, small postinfarction aneurysms to pure, globally dilated ischemic cardiomyopathies.
The calculation of CI helped to characterize regional apical abnormalities. In healthy subjects, CI was 0.60 ± 0.09 in diastole and 0.52 ± 0.10 in systole; significantly lower than in post-MI patients [18]. In the present study, the apical CI was significantly greater in types 1 and 2 compared with type 3, whereas SI (an index of global shape) was greater in type 3. The short axis is significantly greater in type 3, which has the higher rate of associated mitral regurgitation, confirming that the septum-lateral dimension is one of the major determinants of mitral regurgitation [20, 21].
It is commonly reported that the aim of SVR is to rebuild a more elliptical shape, but no studies have demonstrated that the LV is less spherical (ie, more elliptical) postoperatively. Preoperatively, the LV is not more spherical in respect to normal (unless mitral regurgitation is present), because after anterior MI, the elongation of the ventricle is proportional to the increase in width and the ratio does not change [18]. SI in healthy individuals is 0.52 ± 0.06 in diastole and 0.45 ± 0.06 in systole [18]. After SVR, the LV is not more elliptical because the surgical reduction in length always exceeds the reduction in width, despite the use of the conical device to reshape the ventricle.
A recent study by Cirillo and colleagues [22] shows that the eccentricity index (the opposite of the SI) significantly decreases after SVR. The intraventricular conical device allows one to avoid the amputation of the apex, and it is useful to place the new apex in the correct position allowing the alignment with aortic flow tract. Moreover, the device allows one to maintain the long axis of the ventricle in a more physiologic range (7.5/8.5 cm).
The introduction of the CI may help in identifying LV regional shape changes after MI and surgical reshaping procedures. CI reflects apical regional abnormalities, and the increase observed in post-MI patients focuses on a less conical shape. The conical endoventricular device allows apical reconstruction and induces a more conical apical shape in all patients with a significant decrease in CI, whereas the SI does not change or even increases (Table 6). Despite postoperative LV shape being more spherical, all three patient groups do about the same in terms of mortality, cardiac function, and clinical status; this finding suggests that the reduction of LV size and the improvement of apical conicity play the major role on outcome.
Limitations
The number of patients in each category is relatively small in respect to our overall series [23] because we found preoperatively satisfactory in-house echo examinations in only 178 patients, and this may account for bias selection. We do not have cardiac function variables other than ejection fraction, and that is not a good measure of function after SVR because of the marked reduction of EDV induced by the procedure.
Another limitation due to the limited number of patients with few events is that we cannot exclude that having more patients and more events. Type 3 patients might have lower survival rate than the other two groups. Finally, this is an uncontrolled study and the effects of coronary artery bypass grafting and mitral repair on outcome cannot be excluded.
| Conclusions |
|---|
|
|
|---|
We believe that a clear definition of LV shape abnormalities allows the evaluation of SVR outcome and a comparison with other series that otherwise would be impossible. This study does not show a prognostic value of shape classification, but as mentioned in Limitations, it may depend on the limited number of patients and by the few events. We think that time has arrived to redefine the LV aneurysm.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
S. Wakasa, Y. Matsui, T. Isomura, S. Takanashi, A. Yamaguchi, T. Komiya, Y. Cho, J. Kobayashi, H. Yaku, K. Kokaji, et al. Impact of left ventricular remodelling on outcomes after left ventriculoplasty for ischaemic cardiomyopathy: Japanese surgical ventricular reconstruction group experience Interact CardioVasc Thorac Surg, June 1, 2013; 16(6): 785 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goh, D. Prior, A. Newcomb, A. McLellan, J. Mack, S. Callaghan, J. Dimitriou, A. Rosalion, I. Nixon, and M. Yii Surgical Ventricular Restoration Procedure: Single-Center Comparison of Surgical Treatment of Ischemic Heart Failure (STICH) Versus Non-STICH Patients Ann. Thorac. Surg., February 1, 2013; 95(2): 506 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cho, T. Ueda, Y. Inoue, S. Shimura, A. Aki, H. Furuya, K. Okada, and C. Tanaka Long-term results and mid-term features of left ventricular reconstruction procedures on left ventricular volume, geometry, function and mitral regurgitation Eur J Cardiothorac Surg, September 1, 2012; 42(3): 462 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shudo, K. Taniguchi, K. Takeda, T. Sakaguchi, T. Funatsu, H. Matsue, S. Miyagawa, H. Kondoh, S. Kainuma, K. Kubo, et al. Restrictive Mitral Annuloplasty With or Without Surgical Ventricular Restoration in Ischemic Dilated Cardiomyopathy With Severe Mitral Regurgitation Circulation, September 13, 2011; 124(11_suppl_1): S107 - S114. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhong, Y. Su, L. Gobeawan, S. Sola, R.- S. Tan, J. L. Navia, D. N. Ghista, T. Chua, J. Guccione, and G. S. Kassab Impact of surgical ventricular restoration on ventricular shape, wall stress, and function in heart failure patients Am J Physiol Heart Circ Physiol, May 1, 2011; 300(5): H1653 - H1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Jackson and R. C. Gorman Invited Commentary Ann. Thorac. Surg., January 1, 2011; 91(1): 121 - 122. [Full Text] [PDF] |
||||
![]() |
E. A. ten Brinke, R. J. Klautz, S. A. Tulner, H. F. Verwey, J. J. Bax, M. J. Schalij, E. E. van der Wall, M. I. Versteegh, R. A. Dion, and P. Steendijk Long-term effects of surgical ventricular restoration with additional restrictive mitral annuloplasty and/or coronary artery bypass grafting on left ventricular function: Six-month follow-up by pressure-volume loops J. Thorac. Cardiovasc. Surg., December 1, 2010; 140(6): 1338 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Rouleau, R. E. Michler, E. J. Velazquez, J. K. Oh, C. M. O'Connor, P. Desvigne-Nickens, G. Sopko, K. L. Lee, and R. H. Jones The STICH trial: evidence-based conclusions Eur J Heart Fail, October 1, 2010; 12(10): 1028 - 1030. [Full Text] [PDF] |
||||
![]() |
G. D. Buckberg, C. L. Athanasuleas, A. S. Wechsler, F. Beyersdorf, J. V. Conte, and J. E. Strobeck The STICH trial unravelled Eur J Heart Fail, October 1, 2010; 12(10): 1024 - 1027. [Full Text] [PDF] |
||||
![]() |
M. Di Donato, L. Menicanti, M. Ranucci, S. Castelvecchio, C. de Vincentiis, J. Salvia, and T. Yussuf Effects of surgical ventricular reconstruction on diastolic function at midterm follow-up J. Thorac. Cardiovasc. Surg., August 1, 2010; 140(2): 285 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Mann, R. Bogaev, and G. D. Buckberg Cardiac remodelling and myocardial recovery: lost in translation? Eur J Heart Fail, August 1, 2010; 12(8): 789 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pocar, A. Di Mauro, D. Passolunghi, A. Moneta, A. M. T. A. Alsheraei, A. Bregasi, R. Mattioli, and F. Donatelli Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy Eur J Cardiothorac Surg, May 1, 2010; 37(5): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Buckberg and C. L. Athanasuleas The STICH trial: Misguided conclusions J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1060 - 1064. [Full Text] [PDF] |
||||
![]() |
A. Franco-Cereceda Invited Commentary Ann. Thorac. Surg., February 1, 2009; 87(2): 461 - 462. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |